文献速递白血病淋巴瘤

基于甲基化重新定义TAL1阳性T细胞急性淋巴细胞白血病

Towards methylation-based redefinition of TAL1 positive T-cell acute lymphoblastic leukaemia (T-ALL).
PubMed 文献 · Leukemia · 2025-08-08

研究在401例成人和儿童T-ALL队列中用TAL1特异性MS-MLPA检测甲基化,发现单等位TAL1+者呈TAL1低甲基化(甲基化比值<0.4)且表达谱均一,双等位者则富集其他驱动癌基因且转录组与甲基化异质;TAL1低甲基化可识别TAL1失调并与更差预后相关。

要点

  • 单等位TAL1+ T-ALL呈TAL1低甲基化(甲基化比值<0.4)且从不表达其他驱动癌基因。
  • 双等位TAL1+ T-ALL富集TLX1、TLX3、HOXA表达,转录组与TAL1甲基化水平异质。
  • PDX分析中单等位TAL1表达稳定,双等位表达多来自残留非恶性造血细胞。

核心结论

  • TAL1低甲基化可识别TAL1失调,并与更差预后相关。
  • 单等位TAL1+ T-ALL呈均一基因表达谱且TAL1低甲基化(甲基化比值<0.4)。
  • 双等位TAL1+ T-ALL富集其他驱动癌基因表达且转录组与甲基化水平异质。

研究设计与样本

  • 研究纳入大型成人和儿童T-ALL队列(n=401),并设计TAL1特异性MS-MLPA检测甲基化水平。

主要发现

  • 单等位TAL1+ T-ALL呈均一基因表达谱,从不表达其他驱动癌基因,且TAL1低甲基化(甲基化比值<0.4)。
  • 双等位TAL1+ T-ALL富集TLX1、TLX3、HOXA等驱动癌基因表达,转录组与TAL1甲基化水平异质。
  • PDX分析中单等位TAL1表达稳定,双等位表达多来自残留非恶性造血细胞。
  • 研究用长读长纳米孔和OGM分析报告了5种新的TAL1失调机制。

关键数值与推荐

  • 单等位TAL1+ T-ALL的TAL1甲基化比值<0.4,定义为TAL1低甲基化。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

TAL1 is one of the most frequently dysregulated oncogenes in T-cell Acute Lymphoblastic Leukaemia (T-ALL). However, the precise frequency and prognostic impact associated with its dysregulation remains unclear and is confounded by TAL1's diverse dysregulation mechanisms. TAL1 dysregulation is detected by TAL1 transcript quantification, though this technique may be subject to interference by TAL1 transcripts deriving from residual haematological cells that physiologically express high levels of the gene. We hypothesised TAL1 DNA methylation could provide a more reliable biomarker than TAL1 transcript quantification alone. We extensively studied TAL1 dysregulation in a large adult and paediatric T-ALL cohort (n = 401) and designed a TAL1 specific MS-MLPA assay to determine methylation levels. Whereas monoallelic TAL1 + T-ALL had homogeneous gene expression profiles, never expressed other driver oncogenes and were TAL1 hypomethylated (methylation ratio <0.4), biallelic TAL1 + T-ALL were enriched in expression of other driver oncogenes (TLX1, TLX3, HOXA), and had heterogeneous transcriptomes and TAL1 methylation levels. In PDX analysis, monoallelic TAL1 expression was stable, contrary to biallelic expression which mostly derived from residual non-malignant haematopoietic cells. Importantly, we report 5 novel TAL1 dysregulation mechanisms using long-read nanopore and OGM analysis, and show that TAL1 hypomethylation identifies TAL1 dysregulation, and is associated with worse prognosis.

来源:Leukemia,查看原文。版权归原作者所有。

引用

  1. Smith C, Charbonnier G, Simonin M, et al. Towards methylation-based redefinition of TAL1 positive T-cell acute lymphoblastic leukaemia (T-ALL). Leukemia. 2025. PMID: 40781485. doi:10.1038/s41375-025-02714-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。